Dynamic risk assessment in patients with differentiated thyroid cancer

被引:0
|
作者
Abelleira, Erika [1 ]
Jerkovich, Fernando [1 ]
机构
[1] Univ Buenos Aires, Hosp Clin Jose San Martin UBA, Div Endocrinol, Cordoba 2351,5th floor, RA-1120 Cordoba, Buenos Aires, Argentina
关键词
Dynamic risk assessment; Risk of recurrence; Differentiated thyroid cancer; Thyroid cancer; CLINICALLY SIGNIFICANT DISEASE; RADIOIODINE REMNANT ABLATION; FALSE-POSITIVE ABNORMALITIES; RADIOACTIVE IODINE THERAPY; SERIAL NECK ULTRASOUND; QUALITY-OF-LIFE; ACTIVE SURVEILLANCE; PAPILLARY MICROCARCINOMA; STRATIFICATION SYSTEM; MANAGEMENT GUIDELINES;
D O I
10.1007/s11154-023-09857-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The current approach for patients with differentiated thyroid carcinoma should be individualized according to the risk of recurrence, and this stratification could be used to identify the risk of persistent/recurrent disease in three scenarios: preoperatively, immediately postoperatively, and during long-term follow-up. The initial risk of recurrence will tailor the management of the patient in the preoperative and immediate postoperative settings, while the dynamic risk, which considers the responses to treatment, could guide the decision-making process for remnant ablation and long-term management.This review provides a summary of the existing information regarding the dynamic risk of recurrence and recommended management for patients with differentiated thyroid cancer. The application of this approach is essential to avoid unnecessary treatments for most patients who will have a favorable prognosis. On the other hand, it allows specific therapeutic interventions for those patients at high risk of recurrence. In the future, analysis of tumor biology and prospective studies will surely improve the accuracy of recurrence risk prediction.
引用
收藏
页码:79 / 93
页数:15
相关论文
共 50 条
  • [1] Dynamic risk assessment in patients with differentiated thyroid cancer
    Pitoia, Fabian
    Jerkovich, Fernando
    ENDOCRINE-RELATED CANCER, 2019, 26 (10) : R553 - R566
  • [2] Dynamic risk assessment in patients with differentiated thyroid cancer
    Erika Abelleira
    Fernando Jerkovich
    Reviews in Endocrine and Metabolic Disorders, 2024, 25 : 79 - 93
  • [3] Clinical Assessment and Risk Stratification in Differentiated Thyroid Cancer
    Vaisman, Fernanda
    Tuttle, R. Michael
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2019, 48 (01) : 99 - +
  • [4] Validation of dynamic risk stratification in pediatric differentiated thyroid cancer
    Sohn, Seo Young
    Kim, Young Nam
    Kim, Hye In
    Kim, Tae Hyuk
    Kim, Sun Wook
    Chung, Jae Hoon
    ENDOCRINE, 2017, 58 (01) : 167 - 175
  • [5] Extent of Surgery for Low-Risk Differentiated Thyroid Cancer
    McDow, Alexandria D.
    Pitt, Susan C.
    SURGICAL CLINICS OF NORTH AMERICA, 2019, 99 (04) : 599 - +
  • [6] A New Dynamic Response to Therapy Assessment in Postoperative Patients With Low-Risk Differentiated Thyroid Cancer Treated Without Radioactive Iodine
    Dong, Ping
    Wang, Li
    Xiao, Liu
    Yang, Liu
    Huang, Rui
    Li, Lin
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [7] Validation of dynamic risk stratification in pediatric differentiated thyroid cancer
    Seo Young Sohn
    Young Nam Kim
    Hye In Kim
    Tae Hyuk Kim
    Sun Wook Kim
    Jae Hoon Chung
    Endocrine, 2017, 58 : 167 - 175
  • [8] Current practice in intermediate risk differentiated thyroid cancer - a review
    Padovani, Rosalia do Prado
    Duarte, Fernanda Barbosa
    Nascimento, Camila
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2024, 25 (01) : 95 - 108
  • [9] Current practice in intermediate risk differentiated thyroid cancer – a review
    Rosalia do Prado Padovani
    Fernanda Barbosa Duarte
    Camila Nascimento
    Reviews in Endocrine and Metabolic Disorders, 2024, 25 : 95 - 108
  • [10] Thyroid Lobectomy for Low to Intermediate Risk Differentiated Thyroid Cancer
    Hartl, Dana M.
    Guerlain, Joanne
    Breuskin, Ingrid
    Hadoux, Julien
    Baudin, Eric
    Al Ghuzlan, Abir
    Terroir-Cassou-Mounat, Marie
    Lamartina, Livia
    Leboulleux, Sophie
    CANCERS, 2020, 12 (11) : 1 - 18